{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T13:09:37Z","timestamp":1779023377264,"version":"3.51.4"},"reference-count":49,"publisher":"American Association for the Advancement of Science (AAAS)","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T00:00:00Z","timestamp":1628121600000},"content-version":"vor","delay-in-days":216,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002857","name":"China Pharmaceutical University","doi-asserted-by":"publisher","award":["3150120001"],"award-info":[{"award-number":["3150120001"]}],"id":[{"id":"10.13039\/501100002857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LS21H060001"],"award-info":[{"award-number":["LS21H060001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["csbj.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comput Struct Biotechnol J"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.csbj.2021.08.005","type":"journal-article","created":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T11:43:04Z","timestamp":1628250184000},"page":"4472-4485","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Identification of subtypes correlated with tumor immunity and immunotherapy in cutaneous melanoma"],"prefix":"10.34133","volume":"19","author":[{"given":"Qian","family":"Liu","sequence":"first","affiliation":[{"name":"Biomedical Informatics Research Lab, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, China"},{"name":"Cancer Genomics Research Center, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, China"},{"name":"Big Data Research Institute, China Pharmaceutical University, Nanjing 211198, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongfang","family":"Nie","sequence":"additional","affiliation":[{"name":"Biomedical Informatics Research Lab, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, China"},{"name":"Cancer Genomics Research Center, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, China"},{"name":"Big Data Research Institute, China Pharmaceutical University, Nanjing 211198, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengyuan","family":"Li","sequence":"additional","affiliation":[{"name":"Biomedical Informatics Research Lab, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, China"},{"name":"Cancer Genomics Research Center, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, China"},{"name":"Big Data Research Institute, China Pharmaceutical University, Nanjing 211198, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Li","sequence":"additional","affiliation":[{"name":"Biomedical Informatics Research Lab, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, China"},{"name":"Cancer Genomics Research Center, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, China"},{"name":"Big Data Research Institute, China Pharmaceutical University, Nanjing 211198, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiying","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaosheng","family":"Wang","sequence":"additional","affiliation":[{"name":"Biomedical Informatics Research Lab, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, China"},{"name":"Cancer Genomics Research Center, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, China"},{"name":"Big Data Research Institute, China Pharmaceutical University, Nanjing 211198, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"221","published-online":{"date-parts":[[2021,8,18]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2018.27"},{"key":"e_1_3_4_3_2","first-page":"61","article-title":"Immunotherapy of melanoma","volume":"2018","author":"Lugowska I.","year":"2018","unstructured":"Lugowska I., Teterycz P. and Rutkowski P.: Immunotherapy of melanoma. Contemp Oncol (Pozn) 2018; 2018: 61.","journal-title":"Contemp Oncol (Pozn)"},{"key":"e_1_3_4_4_2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12865-018-0285-5","article-title":"Correlate tumor mutation burden with immune signatures in human cancers","volume":"20","author":"Wang X.","year":"2019","unstructured":"Wang X. and Li M.: Correlate tumor mutation burden with immune signatures in human cancers. BMC Immunol 2019; 20: 4.","journal-title":"BMC Immunol"},{"key":"e_1_3_4_5_2","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-14218-7","article-title":"Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1","volume":"11","author":"Imbert C.","year":"2020","unstructured":"Imbert C., Montfort A., Fraisse M., Marcheteau E., Gilhodes J., Martin E. et al: Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1. Nat Commun 2020; 11.","journal-title":"Nat Commun"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-14-0983"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1500596"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa1348"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2015.05.011"},{"key":"e_1_3_4_10_2","article-title":"Classification of triple-negative breast cancers based on Immunogenomic profiling","volume":"37","author":"He Y.","year":"2018","unstructured":"He Y., Jiang Z., Chen C. and Wang X.: Classification of triple-negative breast cancers based on Immunogenomic profiling. J Exp Clin Cancer Res 2018; 37.","journal-title":"J Exp Clin Cancer Res"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.omto.2020.03.021"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.05.044"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3655"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1914-8"},{"key":"e_1_3_4_15_2","doi-asserted-by":"crossref","unstructured":"Badal B et al. Transcriptional dissection of melanoma identifies a high-risk subtype underlying TP53 family genes and epigenome deregulation. JCI Insight 2017;2(9).","DOI":"10.1172\/jci.insight.92102"},{"key":"e_1_3_4_16_2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/jid.2012.283","article-title":"BRAF mutation, NRAS mutation, and the absence of an immune-related expressed gene profile predict poor outcome in patients with stage III melanoma","volume":"133","author":"Mann G.J.","year":"2013","unstructured":"Mann G.J., Pupo G.M., Campain A.E., Carter C.D., Schramm S.-J., Pianova S. et al: BRAF mutation, NRAS mutation, and the absence of an immune-related expressed gene profile predict poor outcome in patients with stage III melanoma. J Invest Dermatol 2013; 133: 509.","journal-title":"J Invest Dermatol"},{"key":"e_1_3_4_17_2","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1752-0509-8-S4-S5","article-title":"Network-based biomarkers enhance classical approaches to prognostic gene expression signatures","volume":"8","author":"Barter R.L.","year":"2014","unstructured":"Barter R.L., Schramm S.-J., Mann G.J. and Yang Y.H.: Network-based biomarkers enhance classical approaches to prognostic gene expression signatures. BMC Syst Biol 2014; 8: S5.","journal-title":"BMC Syst Biol"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad0095"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.02.065"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-16-0019"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.09.028"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1406498"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.44.3762"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad0501"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2014.006"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7"},{"key":"e_1_3_4_27_2","doi-asserted-by":"crossref","DOI":"10.1186\/s40425-018-0367-1","article-title":"Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA)","volume":"6","author":"Danaher P.","year":"2018","unstructured":"Danaher P., Warren S., Lu R., Samayoa J., Sullivan A., Pekker I. et al: Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA). J Immunother Cancer 2018; 6.","journal-title":"J Immunother Cancer"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3612"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506580102"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw1092"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-559"},{"key":"e_1_3_4_32_2","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2011-12-4-r41","article-title":"GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers","volume":"12","author":"Mermel C.H.","year":"2011","unstructured":"Mermel C.H., Schumacher S.E., Hill B., Meyerson M.L., Beroukhim R. and Getz G.: GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol 2011; 12.","journal-title":"Genome Biol"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.03.076"},{"key":"e_1_3_4_34_2","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini Y.","year":"1995","unstructured":"Benjamini Y. and Hochberg Y.: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc B 1995; 57: 289.","journal-title":"J Royal Stat Soc B"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2018.07.012"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2019.07.009"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2018.01.011"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fsi.2005.12.008"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2020.10.030"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf8399"},{"key":"e_1_3_4_41_2","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-12159-9","article-title":"DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load","volume":"10","author":"Jung H.","year":"2019","unstructured":"Jung H., Kim H.S., Kim J.Y., Sun J.-M., Ahn J.S., Ahn M.-J. et al: DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load. Nat Commun 2019; 10.","journal-title":"Nat Commun"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.03.068"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-3139"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.11.052"},{"key":"e_1_3_4_45_2","doi-asserted-by":"crossref","unstructured":"Hong Z et al. Recruitment of mismatch repair proteins to the site of DNA damage in human cells. J Cell Sci 2008;121(Pt 19):3146-54.","DOI":"10.1242\/jcs.026393"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature23465"},{"key":"e_1_3_4_47_2","article-title":"An algorithm to quantify intratumor heterogeneity based on alterations of gene expression profiles","volume":"3","author":"Li M.","year":"2020","unstructured":"Li M., Zhang Z., Li L. and Wang X.: An algorithm to quantify intratumor heterogeneity based on alterations of gene expression profiles. Commun Biol 2020; 3.","journal-title":"Commun Biol"},{"key":"e_1_3_4_48_2","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3892\/ijo.2020.5088","article-title":"Cutaneous melanoma and the immunotherapy revolution (Review)","volume":"57","author":"Leonardi G.","year":"2020","unstructured":"Leonardi G., Candido S., Falzone L., Spandidos D. and Libra M.: Cutaneous melanoma and the immunotherapy revolution (Review). Int J Oncol 2020; 57: 609.","journal-title":"Int J Oncol"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni.f.220"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1818210116"}],"container-title":["Computational and Structural Biotechnology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037021003366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037021003366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.1016\/j.csbj.2021.08.005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T12:50:45Z","timestamp":1779022245000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.1016\/j.csbj.2021.08.005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":49,"alternative-id":["10.1016\/j.csbj.2021.08.005"],"URL":"https:\/\/doi.org\/10.1016\/j.csbj.2021.08.005","relation":{},"ISSN":["2001-0370"],"issn-type":[{"value":"2001-0370","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of subtypes correlated with tumor immunity and immunotherapy in cutaneous melanoma","name":"articletitle","label":"Article Title"},{"value":"Computational and Structural Biotechnology Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.csbj.2021.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology.","name":"copyright","label":"Copyright"}]}}